Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Access Pharma: On track to advance its pipeline
Yahoo/Zacks.com
Thursday, November 4, 2010 - 12:03pm
tags:
Access Pharmaceuticals, earnings
Spectrum Pharma tales 3Q loss as costs rise
Yahoo/AP
Thursday, November 4, 2010 - 12:01pm
tags:
earnings, Spectrum Pharmaceuticals
Investing in Johnson & Johnson While Still Enjoying Diversification
Seeking Alpha
Thursday, November 4, 2010 - 11:51am
tags:
JNJ
Myriad Beats by a Penny
Yahoo/Zacks.com
Thursday, November 4, 2010 - 11:47am
tags:
Myriad, earnings
ChemoCentryx attempts oral autoimmune drug
Fierce Biotech
Thursday, November 4, 2010 - 11:37am
tags:
ChemoCentryx, autoimmune disease
China blesses Sanofi ($SNY) foray into OTC meds
Fierce Pharma
Thursday, November 4, 2010 - 11:35am
tags:
OTC, China, Sanofi, Hangzhou Minsheng
MannKind Accused of Data Fraud Coverup
TheStreet.com
Thursday, November 4, 2010 - 11:33am
tags:
MannKind, fraud, Afrezza, inhaled insulin, diabetes
Onyx lead gainer in drug sector
Marketwatch
Thursday, November 4, 2010 - 11:31am
tags:
earnings, ONYX Pharmaceuticals
Cadence Wins FDA Approval for Painkiller, Now Just Has to Sell It
Seeking Alpha
Thursday, November 4, 2010 - 11:12am
tags:
FDA, painkillers, Cadence Pharmaceuticals, Ofirmev
Inspire Pharma 3Q loss narrows on Azasite sales
Yahoo/AP
Thursday, November 4, 2010 - 11:11am
tags:
earnings, Inspire
Judge Upholds Verdict Against Pfizer Over Neurontin
Pharmalot
Thursday, November 4, 2010 - 11:09am
tags:
Pfizer, Neurontin, epilepsy
Celera Misses, Lowers Outlook
Yahoo/Zacks.com
Thursday, November 4, 2010 - 11:07am
tags:
Celera, earnings
Loss at REGN Wider than Expected
Yahoo/Zacks.com
Wednesday, November 3, 2010 - 7:17pm
tags:
earnings, Regeneron, Sanofi, AstraZeneca
Par Pharma Shares Popped: What You Need to Know
Motley Fool
Wednesday, November 3, 2010 - 7:16pm
tags:
Par Pharmaceutical
Alnylam takes wider 3Q loss as testing costs grow
Yahoo/AP
Wednesday, November 3, 2010 - 7:13pm
tags:
earnings, Alnylam
[video]Amgen in Focus
Yahoo/CNBC
Wednesday, November 3, 2010 - 7:00pm
tags:
Kevin Sharer, Amgen, Pharma CEOs, healthcare reform
Dendreon: Provenge Sales, Guidance Fall Short
TheStreet.com
Wednesday, November 3, 2010 - 6:57pm
tags:
Dendreon, earnings, Provenge
Cell Therapeutics gets NASDAQ reprieve
Bizjournals.com
Wednesday, November 3, 2010 - 1:54pm
tags:
NASDAQ, Cell Therapeutics
Judge combines suits against Pfizer-King merger
Fierce Pharma
Wednesday, November 3, 2010 - 11:46am
tags:
Pfizer, shareholders, King, lawsuits, M&A
Why do Pharmaceutical Sales Representatives hate Scripted Sales Presentations?
Pharmareform
Wednesday, November 3, 2010 - 11:25am
tags:
drug reps

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.